T-cell vaccine
Showing 26 - 50 of >10,000
Prostatic Tumors, Prostate Cancer Trial run by the NCI (Autologus elutriated monocyte vaccine, Multi-epitope (ME) T-cell
Terminated
- Prostatic Neoplasms
- Prostate Cancer
- Autologus elutriated monocyte placebo vaccine
- Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2022
Carcinoma, Melanoma, Bladder Cancer Trial in Chengdu (Tumor antigen-sensitized DC vaccine and their sensitized T cells
Not yet recruiting
- Carcinoma
- +3 more
- Tumor antigen-sensitized DC vaccine and their sensitized T cells subcutaneous administration
-
Chengdu, Sichuan, ChinaWest China Hospital
Feb 10, 2022
Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,
Recruiting
- Recurrent Neuroblastoma
- +3 more
- Cyclophosphamide
- +2 more
-
Palo Alto, California
- +3 more
Jan 25, 2023
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Prostate Cancer, Non Small Cell Lung Cancer, Ovarian Cancer Trial in London, Oxford (OVM-200)
Recruiting
- Prostate Cancer
- +2 more
- OVM-200
-
London, United Kingdom
- +2 more
Apr 26, 2022
COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory
Recruiting
- COVID-19 Infection
- +4 more
- COVID-19 Vaccine
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 2, 2021
COVID-19 Respiratory Infection, Influenza Trial in Tucson (COVID-19 Vaccine)
Recruiting
- COVID-19 Respiratory Infection
- Influenza
- COVID-19 Vaccine
-
Tucson, ArizonaUniversity of Arizona
Sep 28, 2021
COVID-19 Vaccine Responses in PIDD Subjects
Recruiting
- X-linked Agammaglobulinemia
- +6 more
-
Saint Petersburg, Florida
- +2 more
Apr 7, 2022
Malignant Solid Tumour, Breast Cancer, Malignant Tumor of Colon Trial in Columbus (HER-2 vaccine, Extension HER-2 vaccine trial
Recruiting
- Malignant Solid Tumour
- +4 more
- HER-2 vaccine
- Extension HER-2 vaccine trial at OBD
-
Columbus, OhioOhio State University Medical Center
Oct 26, 2021
Influenza Trial in Rochester (FluBlok, Fluzone, FluCelVax)
Completed
- Influenza
- FluBlok
- +3 more
-
Rochester, New YorkUniversity of Rochester Medical Center, Vaccine Research Unit Ro
Nov 1, 2021
COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in
Not yet recruiting
- Follicular Lymphoma
- Cellular immunity vs SARS-CoV-2
- +6 more
-
Alessandria, IT, Italy
- +13 more
Oct 10, 2023
Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)
Active, not recruiting
- Medulloblastoma
- Neuroectodermal Tumor
- TTRNA-xALT
- TTRNA-DCs
-
Los Angeles, California
- +2 more
Jan 7, 2022
Diffuse Hemispheric Glioma, H3 G34-Mutant Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Diffuse Hemispheric Glioma, H3 G34-Mutant
- Dendritic Cell Tumor Peptide Vaccine
- +6 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 13, 2022
Triple Negative Breast Cancer Trial in El Segundo (drug, biological, procedure)
Active, not recruiting
- Triple Negative Breast Cancer
- Aldoxorubicin HCl
- +17 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
Active, not recruiting
- Classical Hodgkin Lymphoma
- +12 more
-
Bedford, Bedfordshire, United Kingdom
- +8 more
Feb 22, 2022
Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)
Not yet recruiting
- Esophageal Cancer
- +3 more
- IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
-
Edegem, BelgiumAntwerp University Hospital
Jul 19, 2023
Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,
Recruiting
- Breast Ductal Carcinoma In Situ
- Granulocyte-Macrophage Colony-Stimulating Factor
- +2 more
-
Jacksonville, Florida
- +1 more
Dec 10, 2021
Metastatic Malignant Melanoma Trial in Oslo (Dendritic cells - transfected with hTERT-, survivin- and tumor cell derived mRNA +
Terminated
- Metastatic Malignant Melanoma
- Dendritic cells - transfected with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion
- Temozolomide
-
Oslo, Montebello, NorwayThe Norwegian Radium Hospital, Department of Clinical Cancer Res
Feb 23, 2021
A T Cell-based HIV Vaccine
Recruiting
- HIV
- HIV positive subjects
- Non-infected control subjects
-
Gainesville, Florida
- +1 more
Feb 11, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic
Not yet recruiting
- Chronic Lymphocytic Leukemia
- COVID-19 Infection
- Biospecimen Collection
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,
Recruiting
- COVID-19 Pandemic
- COVID-19 Vaccines
- Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
- CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
-
Surabaya, East Java, IndonesiaDr. Soetomo General Hospital
Jun 21, 2023
Herpes Zoster Trial in Makati City (REC610, Shingrix)
Recruiting
- Herpes Zoster
- REC610
- Shingrix
-
Makati City, Metro Manila, PhilippinesPharma Peak Research Philippines,Inc.
Mar 13, 2023
Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)
Recruiting
- Extranodal NK T Cell Lymphoma
- NK-Cell Leukemia
- Anti-CD56 CAR T
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023
T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023